Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 2:2022:7888906.
doi: 10.1155/2022/7888906. eCollection 2022.

Exosome-Based Theranostics for Liver Diseases

Nianan Luo  1   2 , Jiangbin Li  1 , Rui Dong  1 , Jianguo Lu  1
Affiliations
Review

Exosome-Based Theranostics for Liver Diseases

Nianan Luo et al. Dis Markers. .

Abstract

Exosomes are small extracellular vesicles that can be secreted by any type of cell, released into almost all biological fluids, and extracted from anybody fluid such as blood, urine, saliva, and amniotic fluid. The theranostic role of exosome in liver diseases has been widely studied in recent years. In this review, we briefly introduce the biological characteristics of exosomes and then focus on the theranostics of exosomes in liver diseases, specifically gene delivery associated with liver diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Exosome-based theranostics for liver diseases. (a) The native or bioengineered exosomes is injected for liver disease therapy in vivo. (b) Exosomes from different liver cell types are isolated for liver diseases diagnosis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Tellez L., Rodriguez-Santiago E., Albillos A. Fontan-associated liver disease: a review. Annals of Hepatology . 2018;17(2):192–204. doi: 10.5604/01.3001.0010.8634. - DOI - PubMed
    1. Mohammed A., Paranji N., Chen P. H., Niu B. COVID-19 in chronic liver disease and liver transplantation: a clinical review. Journal of Clinical Gastroenterology . 2021;55(3):187–194. doi: 10.1097/MCG.0000000000001481. - DOI - PMC - PubMed
    1. Osna N. A., Donohue T. M., Jr., Kharbanda K. K. Alcoholic liver disease: pathogenesis and current management. Alcohol Research: Current Reviews . 2017;38(2):147–161. - PMC - PubMed
    1. Stickel F., Datz C., Hampe J., Bataller R. Pathophysiology and management of alcoholic liver disease: update 2016. Gut Liver . 2017;11(2):173–188. doi: 10.5009/gnl16477. - DOI - PMC - PubMed
    1. Xanthopoulos A., Starling R. C., Kitai T., Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail . 2019;7(2):87–97. doi: 10.1016/j.jchf.2018.10.007. - DOI - PubMed